Mkts

Prelude Therapeutics Incorporated

NASDAQ: PRLD
$3.30-0.02 (-0.60%)
As of Nov 18, 4:00 PM ET

Key statistics

Day range
3.283.43
52-week range
1.296.83
Today
Open3.32
Previous close3.30
Volume—
Valuation
Market cap265.35M
P/E ratio—
EPS (TTM)-0.73
Income & risk
Dividend / yield—
Beta1.28
Avg volume446.9K
Discussion

PRLD News

Stories mentioning PRLD from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue4,5806,5000.003,000
Cost of Goods Sold
Gross Profit0.000.00
Operating Expenses
Research & Development13,60117,99221,70825,78428,81631,62029,45729,509
Sales General & Admin
Total Operating Expenses18,75722,98826,91832,19434,60637,83137,37637,164
Operating Income (Loss)(14,177)(17,348)(20,418)(32,194)(34,606)(33,831)(34,376)(37,164)
Interest Income
Interest Expense
Other Expense3,792891.00693.00963.002,5215,1002,1052,424
Pretax Income
Tax Provision
Net Income (Loss)(10,385)(16,457)(19,725)(31,231)(32,085)(28,731)(32,271)(34,740)
Earnings Per Share (Basic)(0.13)(0.21)(0.26)(0.41)(0.42)(0.38)(0.43)(0.46)
Earnings Per Share (Diluted)(0.13)(0.21)(0.26)(0.41)(0.42)(0.38)(0.43)(0.46)
Weighted Average Shares Outstanding (Basic)82,52076,95676,13275,99475,98675,80675,85675,762
Weighted Average Shares Outstanding (Diluted)82,52076,95676,13275,99475,98675,80675,85675,762

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About PRLD

Prelude Therapeutics Incorporated (NASDAQ: PRLD) is a stock listed on the Nasdaq Stock Market under the ticker symbol PRLD. It last traded at $3.30 (Nov 18, 2026, 4:00 PM ET), down 0.6% on the day. That gives Prelude Therapeutics a market capitalisation of $265.3M.

Over the past 52 weeks PRLD has traded between $1.29 and $6.83.

Revenue for the quarter ended Mar 31, 2026 was $4.6M; a net loss of $10.4M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$4.6M-$10.4M-226.7%
Dec 31, 2025—-$16.5M—
Sep 30, 2025$6.5M-$19.7M-303.5%
Jun 30, 2025—-$31.2M—

From Prelude Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…